06.03.2025 |
BioStock interview with CEO John Glasspool on VMX-C001 at BioCapital Europe
Related items
08.07.2025
Enables initiation of global EquilibriX-S trial later this year Critical milestone in development of novel bypass agent to restore coagulation,…